EX-21.1 2 gild2017form10-kexhibit211.htm EXHIBIT 21.1 LISTING OF SUBSIDIARIES Exhibit



Exhibit 21.1


SUBSIDIARIES OF GILEAD SCIENCES, INC.
(as of December 31, 2017)
 
 
Name of Subsidiary
Country of Incorporation
Bristol-Myers Squibb and Gilead Sciences Limited
Ireland
Bristol-Myers Squibb & Gilead Sciences, LLC*
United States
Cytopia Pty. Ltd.
Australia
EpiTherapeutics ApS
Denmark
Gilead Alberta ULC
Canada
Gilead Alberta, LLC
United States
Gilead Apollo, LLC
United States
Gilead Apollo Unlimited Company
Ireland
Gilead Biopharmaceutics Ireland UC
Ireland
Gilead Calistoga, LLC
United States
Gilead Connecticut, Inc.
United States
Gilead Holdings, LLC
United States
Gilead Ireland Research UC
Ireland
Gilead Oncology Ireland UC
Ireland
Gilead Pharmasset LLC
United States
Gilead Sciences (NZ)
New Zealand
Gilead Sciences (Shanghai) Consulting Co., Ltd.
China
Gilead Sciences (Thailand) Limited
Thailand
Gilead Sciences Americas S. de R.L.
Panama
Gilead Sciences Argentina S.R.L.
Argentina
Gilead Sciences Belgium BVBA
Belgium
Gilead Sciences Canada, Inc.
Canada
Gilead Sciences Denmark ApS
Denmark
Gilead Sciences Europe Limited
United Kingdom
Gilead Sciences Farmacêutica do Brasil Ltda.
Brazil
Gilead Sciences Finland Oy
Finland
Gilead Sciences GesmbH.
Austria
Gilead Sciences GmbH
Germany
Gilead Sciences Hangzhou Pharmaceutical Co., Ltd.
China
Gilead Sciences Hellas EPE
Greece
Gilead Sciences Holding, LLC
United States
Gilead Sciences Hong Kong Limited
Hong Kong
Gilead Sciences International Limited
United Kingdom
Gilead Sciences Israel Limited
Israel
Gilead Sciences KK
Japan
Gilead Sciences Korea Limited
South Korea
Gilead Sciences Lda.
Portugal
Gilead Sciences Ireland UC
Ireland
Gilead Sciences llac Ticaret Limited Sirketi
Turkey
Gilead Sciences Limited
United Kingdom
Gilead Sciences Luxembourg S.a.r.l.
Luxembourg




Exhibit 21.1

SUBSIDIARIES OF GILEAD SCIENCES, INC. (continued)
Name of Subsidiary
Country of Incorporation
Gilead Sciences Malaysia Sdn. Bhd.
Malaysia
Gilead Sciences Mexico S. de R.L. de C.V.
Mexico
Gilead Sciences Netherlands BV
Netherlands
Gilead Sciences Norway AS
Norway
Gilead Sciences Poland Sp. z o.o.
Poland
Gilead Sciences Pty. Ltd.
Australia
Gilead Sciences Russia LLC
Russia
Gilead Sciences S.L.U.
Spain
Gilead Sciences S.r.l.
Italy
Gilead Sciences s.r.o.
Czech Republic
Gilead Sciences SAS
France
Gilead Sciences Singapore Pte. Ltd.
Singapore
Gilead Sciences Slovakia s.r.o.
Slovakia
Gilead Sciences South Africa (Pty) Ltd.
South Africa
Gilead Sciences Sweden AB
Sweden
Gilead Sciences Switzerland Sarl
Switzerland
Gilead Sciences YM Australia Pty. Ltd.
Australia
Gilead YM ULC
Canada
Gilead India Private Limited
India
Nimbus Ceres LLC
United States
Tri-Supply Limited
Ireland
YM BioSciences Australia Pty. Ltd.
Australia
Gilead Therapeutics A1 Unlimited Company
Ireland
Gilead Therapeutics A2 Unlimited Company
Ireland
Gilead Sciences Shanghai Pharmaceutical Technology Co., Ltd.
China
Kite Pharma, Inc.
United States
Kite Pharma, LLC
United States
neoKite, Inc.
United States
Kite Pharma UK, Ltd
United Kingdom
KP EU C.V.
Netherlands
Kite Pharma EU B.V.
Netherlands
Cell Design Labs, Inc.
United States

* Effective January 1, 2018, Bristol-Myers Squibb & Gilead Sciences, LLC was renamed as Gilead Sciences, LLC. See Note 10, Collaborative Arrangements of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for additional information.